{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for valproic root_modifications_structuralModifications_molecularFragment_refPname in root_modifications_structuralModifications_molecularFragment_refPname (approximate match)
Status:
Investigational
Source:
INN:dalnicastobart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04584697: Phase 1/Phase 2 Interventional Withdrawn Covid19
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04596150: Phase 2 Interventional Completed Neoplasms
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:ralzapastotug [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01042379: Phase 2 Interventional Recruiting Breast Neoplasms
(2010)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:umesolerbart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:sudocetaxel zendusortide [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT04659031: Phase 1 Interventional Completed Inclusion Body Myositis
(2021)
Source URL:
Class:
PROTEIN
